Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1

Increasing evidence suggests that prostate cancer is over diagnosed and over treated, and prognostic biomarkers would aid in treatment selection. To define prognostic biomarkers for aggressive prostate cancer, we carried out gene expression profiling of 98 prostate tumors and 52 benign adjacent pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulzar, Zulfiqar G, McKenney, Jesse K., Brooks, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360134/
https://www.ncbi.nlm.nih.gov/pubmed/22349817
http://dx.doi.org/10.1038/onc.2012.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360134/
https://www.ncbi.nlm.nih.gov/pubmed/22349817
http://dx.doi.org/10.1038/onc.2012.27

Ejemplares similares